HBV cccDNA转录调控机制与抗HBV治疗前景

陈娟; 黄爱龙

doi:10.3969/j.issn.1001-5256.2019.06.004

HBV cccDNA转录调控机制与抗HBV治疗前景

DOI: 10.3969/j.issn.1001-5256.2019.06.004

陈娟,
黄爱龙

基金项目:

国家自然科学基金(81672012,81871656,818110109)；

详细信息

中图分类号: R512.62
计量
- 文章访问数: 1837
- HTML全文浏览量: 52
- PDF下载量: 385
- 被引次数: 0
出版历程
- 收稿日期: 2019-04-04
- 出版日期: 2019-06-20

Epigenetic regulation of hepatitis B virus cccDNA and related prospects for antiviral therapy

Research funding:

摘要

摘要: 以微染色体形式存在的HBV共价闭合环状DNA(cccDNA)在肝细胞核内持续稳定的存在,被认为是HBV感染慢性化、抗病毒治疗无法清除病毒以及停药后肝炎复发的最主要原因。然而,现有各种抗病毒治疗方案中,缺少以cccDNA本身或形成、转录等环节为靶点的药物,因此,靶向cccDNA环节的治疗策略是急需填补的空白。随着对cccDNA微染色体上组蛋白表观遗传修饰的逐步解析,表观遗传治疗也有望成为HBV新的潜在治疗方向。主要关注了HBV DNA甲基化和cccDNA组蛋白修饰的研究现状和发展方向,试图为HBV表观遗传治疗提供思路。
- 乙型肝炎病毒 /
- 基因调控网络 /
- 共价闭合环状DNA /
- 基因,修饰
Abstract: Hepatitis B virus (HBV) covalently closed circular DNA (cccDNA) is stably maintained in hepatocytes in the form of minichromosome and is considered the most important cause of chronicity of HBV infection, presence of HBV after antiviral therapy, and recurrence of hepatitis after drug withdrawal. However, due to a lack of antiviral regimens targeting cccDNA itself or the formation and transcription of cccDNA, there is an urgent need for treatment strategies targeting cccDNA. With the gradual understanding of epigenetic modification of histones of the cccDNA minichromosome, epigenetic therapy is expected to become a potential therapy for HBV. This article reviews the current status and future directions of HBV DNA methylation and cccDNA-bound histone modification, in order to provide new thoughts for epigenetic therapy for HBV.
- hepatitis B virus /
- gene regulatory networks /
- cccDNA /
- genes, modifier

HTML全文

参考文献(57)

[1]Polaris Observatory Collaborators.Global prevalence, treatment, and prevention of hepatitis B virus infection in 2016:Amodelling study[J].Lancet Gastroenterol Hepatol, 2018, 3 (6) :383-403.

[2]LIN CL, YANG HC, KAO JH.Hepatitis B virus:New therapeutic perspectives[J].Liver Int, 2016, 36 (Suppl 1) :85-92.

[3]GERLICH WH, ROBINSON WS.Hepatitis B virus contains protein attached to the 5'terminus of its complete DNA strand[J].Cell, 1980, 21 (3) :801-809.

[4]MOLNAR-KIMBER KL, SUMMERS J, TAYLOR JM, et al.Protein covalently bound to minus-strand DNA intermediates of duck hepatitis B virus[J].J Virol, 1983, 45 (1) :165-172.

[5]MASON WS, HALPERN MS, ENGLAND JM, et al.Experimental transmission of duck hepatitis B virus[J].Virology, 131 (1983) :375-384.

[6]MILLER RH, ROBINSON WS.Hepatitis B virus DNA forms in nuclear and cytoplasmic fractions of infected human liver[J].Virology, 1983, 131 (2) :375-384.

[7]TAGAWA M, OMATA M, YOKOSUKA O, et al.Early events in duck hepatitis B virus infection.Sequential appearance of viral deoxyribonucleic acid in the liver, pancreas, kidney, and spleen[J].Gastroenterology, 1985, 89 (6) :1224-1229.

[8]TUTTLEMAN JS, POURCEL C, SUMMERS J.Formation of the pool of covalently closed circular viral DNA in hepadnavirusinfected cells[J].Cell, 1986, 47 (3) :451-460.

[9]BOCK CT, SCHRANZ P, SCHRDER CH, et al.Hepatitis Bvirus genome is organized into nucleosomes in the nucleus of the infected cell[J].Virus Genes, 1994, 8 (3) :215-229.

[10]NEWBOLD JE, XIN H, TENCZA M, et al.The covalently closed duplex form of the hepadnavirus genome exists in situ as a heterogeneous population of viral minichromosomes[J].J Virol, 1995, 69 (6) :3350-3357.

[11]ZHANG Y, LI C, ZHANG Y, et al.Comparative analysis of CpG islands among HBV genotypes[J].PLo S One, 2013, 8 (2) :e56711.

[12]ZHANG Y, MAO R, YAN R, et al.Transcription of hepatitis Bvirus covalently closed circular DNA is regulated by CpG methylation during chronic infection[J].PLo S One, 2014, 9 (10) :e110442.

[13]JAIN S, CHANG TT, CHEN S, et al.Comprehensive DNAmethylation analysis of hepatitis B virus genome in infected liver tissues[J].Sci Rep, 2015, 5:10478.

[14]GUO Y, LI YN, ZHAO JR, et al.HBc binds to the CpGislands of HBV cccDNA and promotes an epigenetic permissive state[J].Epigenetics, 2011, 6 (6) :720-726.

[15]LEE H, JEONG H, LEE SY, et al.Hepatitis B virus X protein stimulates virus replication via DNA methylation of the C-1619in covalently closed circular DNA[J].Mol Cells, 2019, 42 (1) :67-78.

[16]IMAM H, KHAN M, GOKHALE NS, et al.N6-methyladenosine modification of hepatitis B virus RNA differentially regulates the viral life cycle[J].Proc Natl Acad Sci U S A, 2018, 115 (35) :8829-8834.

[17]MATSUDA Y, ICHIDA T.p16 and p27 are functionally correlated during the progress of hepatocarcinogenesis[J].Med Mol Morphol, 2006, 39 (4) :169-175.

[18]KOUZARIDES T.Chromatin modifications and their function[J].Cell, 2007, 128 (4) :693-705.

[19]RODRGUEZ-PAREDES M, ESTELLER M.Cancer epigenetics reaches mainstream oncology[J].Nat Med, 2011, 17 (3) :330-339.

[20]ZHANG W, CHEN J, WU M, et al.PRMT5 restricts hepatitis Bvirus replication through epigenetic repression of covalently closed circular DNA transcription and interference with pregenomic RNA encapsidation[J].Hepatology, 2017, 66 (2) :398-415.

[21]BEDFORD MT, RICHARD S.Arginine methylation an emerging regulator of protein function[J].Mol Cell, 2005, 18 (3) :263-272.

[22]VIVEKANANDAN P, DANIEL HD, KANNANGAI R, et al.Hepatitis B virus replication induces methylation of both host and viral DNA[J].J Virol, 2010, 84 (9) :4321-4329.

[23]RIVIRE L, GEROSSIER L, DUCROUX A, et al.HBx relieves chromatin-mediated transcriptional repression of hepatitis Bviral cccDNA involving SETDB1 histone methyltransferase[J].J Hepatol, 2015, 63 (5) :1093-1102.

[24]DUCROUX A, BENHENDA S, RIVIRE L, et al.The Tudor domain protein Spindlin1 is involved in intrinsic antiviral defense against incoming hepatitis B virus and herpes simplex virus type 1[J].PLo S Pathog, 2014, 10 (9) :e1004343.

[25]ALARCON V, HERNNDEZ S, RUBIO L, et al.The enzymes LSD1 and Set1A cooperate with the viral protein HBx to establish an active hepatitis B viral chromatin state[J].Sci Rep, 2016, 6:25901.

[26]PRADEEPA MM, GRIMES GR, KUMAR Y, et al.Histone H3globular domain acetylation identifies a new class of enhancers[J].Nat Genet, 2016, 48 (6) :681-686.

[27]POLLICINO T, BELLONI L, RAFFA G, et al.Hepatitis B virus replication is regulated by the acetylation status of hepatitis Bvirus cccDNA-bound H3 and H4 histones[J].Gastroenterology, 2006, 130 (3) :823-837.

[28]BELLONI L, ALLWEISS L, GUERRIERI F, et al.IFN-alpha inhibits HBV transcription and replication in cell culture and in humanized mice by targeting the epigenetic regulation of the nuclear cccDNA minichromosome[J].J Clin Invest, 2012, 122 (2) :529-537.

[29]REN JH, HU JL, CHENG ST, et al.SIRT3 restricts hepatitis Bvirus transcription and replication through epigenetic regulation of covalently closed circular DNA involving suppressor of variegation 3-9 homolog 1 and SET domain containing 1A histone methyltransferases[J].Hepatology, 2018, 68 (4) :1260-1276.

[30]HONG X, KIM ES, GUO H.Epigenetic regulation of hepatitis B virus covalently closed circular DNA:Implications for epigenetic therapy against chronic hepatitis B[J].Hepatology, 2017, 66 (6) :2066-2077.

[31]BELLONI L, POLLICINO T, de NICOLA F, et al.Nuclear HBx binds the HBV minichromosome and modifies the epigenetic regulation of cccDNA function[J].Proc Natl Acad Sci U S A, 2009, 106 (47) :19975-19979.

[32]WEI W, LIU X, CHEN J, et al.Class I histone deacetylases are major histone decrotonylases:Evidence for critical and broad function of histone crotonylation in transcription[J].Cell Res, 2017, 27 (7) :898-915.

[33]WANG Y, GUO YR, LIU K, et al.KAT2A coupled with the alpha-KGDH complex acts as a histone H3 succinyltransferase[J].Nature, 2017, 552 (7684) :273-277.

[34]KEBEDE AF, NIEBORAK A, SHAHIDIAN LZ, et al.Histone propionylation is a mark of active chromatin[J].Nat Struct Mol Biol, 2017, 24 (12) :1048-1056.

[35]ISHIGURO T, TANABE K, KOBAYASHI Y, et al.Malonylation of histone H2A at lysine 119 inhibits Bub1-dependent H2Aphosphorylation and chromosomal localization of shugoshin proteins[J].Sci Rep, 2018, 8 (1) :7671.

[36]LU Y, XU Q, LIU Y, et al.Dynamics and functional interplay of histone lysine butyrylation, crotonylation, and acetylation in rice under starvation and submergence[J].Genome Biol, 2018, 19 (1) :144.

[37]XU YM, DU JY, LAU AT.Posttranslational modifications of human histone H3:An update[J].Proteomics, 2014, 14 (17-18) :2047-2060.

[38]JBARA M, GUTTMANN-RAVIV N, MAITY SK, et al.Total chemical synthesis of methylated analogues of histone 3 revealed KDM4D as a potential regulator of H3K79me3[J].Bioorg Med Chem, 2017, 25 (18) :4966-4970.

[39]DALL'OLIO F, TRINCHERA M.Epigenetic bases of aberrant glycosylation in cancer[J].Int J Mol Sci, 2017, 18 (5) :998.

[40]KONOPLEVA M, LETAI A.BCL-2 inhibition in AML:An unexpected bonus?[J].Blood, 2018, 132 (10) :1007-1012.

[41]SANTINI V.How I treat MDS after hypomethylating agent failure[J].Blood, 2019, 133 (6) :521-529.

[42]STONE ML, CHIAPPINELLI KB, LI H, et al.Epigenetic therapy activates type I interferon signaling in murine ovarian cancer to reduce immunosuppression and tumor burden[J].Proc Natl Acad Sci U S A, 2017, 114 (51) :e10981-e10990.

[43]LIU M, ZHANG L, LI H, et al.Integrative epigenetic analysis reveals therapeutic targets to the DNA methyltransferase inhibitor guadecitabine (SGI-110) in hepatocellular carcinoma[J].Hepatology, 2018, 68 (4) :1412-1428.

[44]SU Y, HOPFINGER NR, NGUYEN TD, et al.Epigenetic reprogramming of epithelial mesenchymal transition in triple negative breast cancer cells with DNA methyltransferase and histone deacetylase inhibitors[J].J Exp Clin Cancer Res, 2018, 37 (1) :314.

[45]SONG Q, LI M, FAN C, et al.A novel benzamine lead compound of histone deacetylase inhibitor ZINC24469384 can suppresses HepG2 cells proliferation by upregulating NR1H4[J].Sci Rep, 2019, 9 (1) :2350.

[46]SUN G, MACKEY LV, COY DH, et al.The histone deacetylase inhibitor vaproic acid induces cell growth arrest in hepatocellular carcinoma cells via suppressing notch signaling[J].JCancer, 2015, 6 (10) :996-1004.

[47]LOPES-COELHO F, SILVA F, HIPLITO A, et al.Acetylation drives hepatocyte nuclear factor 1 beta stability by blocking proteasome-mediated degradation[J].J Cell Biochem, 2019, 120 (6) :9337-9344.

[48]OZAKI T, WU D, SUGIMOTO H, et al.Runt-related transcription factor 2 (RUNX2) inhibits p53-dependent apoptosis through the collaboration with HDAC6 in response to DNAdamage[J].Cell Death Dis, 2013, 4:e610.

[49]MARKS PA, XU WS.Histone deacetylase inhibitors:Potential in cancer therapy[J].J Cell Biochem, 2009, 107 (4) :600-608.

[50]BLAGITKO-DORFS N, SCHLOSSER P, GREVE G, et al.Combination treatment of acute myeloid leukemia cells with DNMT and HDAC inhibitors:Predominant synergistic gene downregulation associated with gene body demethylation[J].Leukemia, 2019, 33 (4) :945-956.

[51]HUANG D, CUI L, AHMED S, et al.An overview of epigenetic agents and natural nutrition products targeting DNA methyltransferase, histone deacetylases and microRNAs[J].Food Chem Toxicol, 2019, 123:574-594.

[52]BROCKS D, SCHMIDT CR, DASKALAKIS M, et al.Erratum:DNMT and HDAC inhibitors induce cryptic transcription start sites encoded in long terminal repeats[J].Nat Genet, 2017, 49 (11) :1661.

[53]CHOVANEC M, TAZA F, KALRA M, et al.Incorporating DNAmethyltransferase inhibitors (DNMTis) in the treatment of genitourinary malignancies:A systematic review[J].Target Oncol, 2018, 13 (1) :49-60.

[54]BRUYER A, MAES K, HERVIOU L, et al.DNMTi/HDACi combined epigenetic targeted treatment induces reprogramming of myeloma cells in the direction of normal plasma cells[J].Br JCancer, 2018, 118 (8) :1062-1073.

[55]CHEN K, LIU J, LIU S, et al.Methyltransferase SETD2-mediated methylation of STAT1 is critical for interferon antiviral activity[J].Cell, 2017, 170 (3) :492-506.e414.

[56]ALCENDOR RR, KIRSHENBAUM LA, IMAI S, et al.Silent information regulator 2alpha, a longevity factor and class III histone deacetylase, is an essential endogenous apoptosis inhibitor in cardiac myocytes[J].Circ Res, 2004, 95 (10) :971-980.

[57]WEI ZQ, ZHANG YH, KE CZ, et al.Curcumin inhibits hepatitis B virus infection by down-regulating cccDNA-bound histone acetylation[J].World J Gastroenterol, 2017, 23 (34) :6252-6260.

施引文献

资源附件(0)

访问统计